TKTL-1 expression in lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metabolism

Background:

• Malignancy involves metabolic shifts, including increased glucose uptake and lactate production.
• Aerobic glycolysis, or the Warburg effect, is a key metabolic adaptation in cancer cells.
• Transketolase-like protein 1 (TKTL1) is implicated in carcinogenesis via aerobic glycolysis and hypoxia-inducible factor alpha stabilization.

Purpose of the Study:

• To investigate the expression of TKTL1 protein in lung cancer patients.
• To determine the correlation between TKTL1 expression and clinicopathological features and survival outcomes.

Main Methods:

• Immunohistochemistry was used to detect TKTL1 protein expression in 197 lung cancer patient samples.
• Analysis included correlation with TNM staging, grading, survival, smoking status, and gender.

Main Results:

• Moderate to strong TKTL1 expression was observed in 39.1% of lung cancer patients.
• A complete lack of TKTL1 expression was found in 12.7% of cases, predominantly small cell lung cancer (SCLC).
• No significant correlation was found between TKTL1 expression and overall survival, disease-free survival, TNM variables, grading, stage, smoking status, or gender.

Conclusions:

• TKTL1 protein is expressed in a subset of lung cancer patients.
• TKTL1 expression does not correlate with established prognostic factors in this cohort.
• TKTL1 represents a potential therapeutic target for specific lung cancer cases.